Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFOTAXIME vs CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFOTAXIME vs CEFTAZIDIME: Safety Overview

Metric CEFOTAXIME CEFTAZIDIME
Total FAERS Reports 3,298 3,158
Deaths Reported 557 696
Death Rate 16.9% 22.0%
Hospitalizations 1,932 1,503
Average Patient Age 46.7 yrs 52.0 yrs
% Female Patients 40.4% 43.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 1989
Manufacturer SteriMax Inc. Hospira, Inc.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued Discontinued